The induction of ferroptosis-like cell death by the inhibition of GPX4 and FSP1 may be an effective treatment for GC refractory to conventional chemotherapy, and a combination of unknown cell death mechanisms may improve the prognosis of patients with GC. Here, GPX4 is linked to gastric cancer.